A bioactive nanocomposite sponge for simultaneous hemostasis and antimicrobial therapy

Uncontrollable bleeding and bacterial infections are the major reasons for the high mortality of post-traumatic.In this study,a composite hemostatic chitosan sponge CaO_(2)@SiO_(2)/CS was prepared by combining a novel core-shell inorganic nano hemostatic CaO_(2)@SiO_(2)nanoparticles with carboxylated chitosan,which presents a multi-layered structure with a rough and hydrophilic surface for rapid absorption of blood.When the CaO_(2)@SiO_(2)nanoparticles in the CaO_(2)@SiO_(2)/CS come into contact with blood,the silanol group on its surface and the released H_(2)O_(2)and Ca2+can recruit and activate platelets,while generating fibrin clots and activating the endo-exogenous coagulation cascade reaction to achieve rapid clotting.The H_(2)O_(2)released from CaO_(2)@SiO_(2)shows the antimicrobial capacity and stimulates the production of tissue factors by endothelial cells.Meanwhile,the silica coating reduces the cytotoxicity of bare CaO_(2),thus reducing the risk of secondary bleeding at the site of vascular injury.CaO_(2)@SiO_(2)/CS(48 s)showed a 1.83-and 2.52-fold reduction in hemostasis time compared to commercial gelfoam and CS in a femoral artery hemorrhage model.This study illustrates the hemostatic mechanism of CaO_(2)@SiO_(2)and provides a reference for the development of clinical biomedical inorganic hemostatic materials.

Cryo-self-assembled silk fibroin sponge as a biodegradable platform for enzyme-responsive delivery of exosomes

Although advances in protein assembly preparation have provided a new platform for drug delivery during tissue engineering,achieving long-term controlled exosome delivery remains a significant challenge.Diffusion-dominated exosome release using protein hydrogels results in burst release of exosomes.Here,a fibroin-based cryo-sponge was developed to provide controlled exosome release.Fibroin chains can self-assemble into silk I structures under ice-cold conditions when annealed above the glass transition temperature.Exosome release is enzyme-responsive,with rates primarily determined by enzymatic degradation of the scaffolds.In vivo experiments have demonstrated that exosomes remain in undigested sponge material for two months,superior to their retention in fibrin glue,a commonly used biomaterial in clinical practice.Fibroin cryo-sponges were implanted subcutaneously in nude mice.The exosome-containing sponge group exhibited better neovascularization and tissue ingrowth effects,demonstrating the efficacy of this exosome-encapsulating strategy by realizing sustained release and maintaining exosome bioactivity.These silk fibroin cryo-sponges containing exosomes provide a new platform for future studies of exosome therapy.